Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineered skin bacteria induce antitumor T cell responses against melanoma
Y. Erin Chen, Djenet Bousbaine, Alessandra Veinbachs, et al.
Science (2023) Vol. 380, Iss. 6641, pp. 203-210
Closed Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Engineered Living Materials for Advanced Diseases Therapy
Dong Xue, Wei Wu, Pei Pan, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 52
Bacterial therapies at the interface of synthetic biology and nanomedicine
Jaeseung Hahn, Suwan Ding, Jongwon Im, et al.
Nature Reviews Bioengineering (2023) Vol. 2, Iss. 2, pp. 120-135
Closed Access | Times Cited: 46
Role of the microbiota in response to and recovery from cancer therapy
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 46
Biomimetic piezoelectric nanomaterial-modified oral microrobots for targeted catalytic and immunotherapy of colorectal cancer
Yueyue Fan, Jiamin Ye, Yong Kang, et al.
Science Advances (2024) Vol. 10, Iss. 19
Open Access | Times Cited: 34
Glioblastoma vaccines: past, present, and opportunities
Zujian Xiong, Itay Raphael, Michael R. Olin, et al.
EBioMedicine (2024) Vol. 100, pp. 104963-104963
Open Access | Times Cited: 29
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
Andrew Redenti, Jongwon Im, Benjamin Redenti, et al.
Nature (2024) Vol. 635, Iss. 8038, pp. 453-461
Open Access | Times Cited: 25
The Multifaceted Role of Tissue-Resident Memory T Cells
Susan N. Christo, Simone L. Park, Scott N. Mueller, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 317-345
Closed Access | Times Cited: 24
Design and regulation of engineered bacteria for environmental release
Yonatan Chemla, Connor J. Sweeney, Christopher A. Wozniak, et al.
Nature Microbiology (2025) Vol. 10, Iss. 2, pp. 281-300
Closed Access | Times Cited: 4
Engineered Bacteria for Disease Diagnosis and Treatment Using Synthetic Biology
Kai Jin, Yi Huang, Hailong Che, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 3
A multi-omics spatial framework for host-microbiome dissection within the intestinal tissue microenvironment
Bokai Zhu, Yunhao Bai, Yao Yu Yeo, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Synthetically programmed antioxidant delivery by a domesticated skin commensal
Guillermo Nevot, Javier Santos‐Moreno, Nil Campamà Sanz, et al.
Cell Systems (2025) Vol. 16, Iss. 2, pp. 101169-101169
Open Access | Times Cited: 2
Mapping the T cell repertoire to a complex gut bacterial community
Kazuki Nagashima, Aishan Zhao, Katayoon Atabakhsh, et al.
Nature (2023) Vol. 621, Iss. 7977, pp. 162-170
Open Access | Times Cited: 39
The human microbiome and cancer: a diagnostic and therapeutic perspective
Shruthi Kandalai, Huapeng Li, Nan Zhang, et al.
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 38
Melanoma and microbiota: Current understanding and future directions
Bertrand Routy, Tanisha Jackson, Laura Mählmann, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 16-34
Open Access | Times Cited: 31
Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets
Jia‐Hao Dai, Xi-Rong Tan, Han Qiao, et al.
Protein & Cell (2023) Vol. 15, Iss. 4, pp. 239-260
Open Access | Times Cited: 23
Delivery of a sebum modulator by an engineered skin microbe in mice
Nastassia Knödlseder, María-José Fábrega, Javier Santos‐Moreno, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 11, pp. 1661-1666
Open Access | Times Cited: 14
Discovery and engineering of the antibody response to a prominent skin commensal
Djenet Bousbaine, Katherine D. Bauman, Y. Erin Chen, et al.
Nature (2024)
Closed Access | Times Cited: 12
Engineering bacteria for cancer immunotherapy
Jesse G. Zalatan, Lorenzo Petrini, Roger Geiger
Current Opinion in Biotechnology (2024) Vol. 85, pp. 103061-103061
Open Access | Times Cited: 11
Engineered bacteria in tumor immunotherapy
Hua Chen, Yinrui Zhu, Chonghai Zhang, et al.
Cancer Letters (2024) Vol. 589, pp. 216817-216817
Closed Access | Times Cited: 11
Multi-omics signatures reveal genomic and functional heterogeneity of Cutibacterium acnes in normal and diseased skin
Tianze Yu, Xiaoqiang Xu, Yang Liu, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 7, pp. 1129-1146.e8
Closed Access | Times Cited: 11
Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments
Lisa Feldman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Engineering Strategies to Modulate the Gut Microbiome and Immune System
Kai Han, Jin Xu, Fang Xie, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 2, pp. 208-215
Closed Access | Times Cited: 9
Advances in Radionuclide-Labeled Biological Carriers for Tumor Imaging and Treatment
Yaozhang Yang, Jing Wang, Yan Zhong, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access | Times Cited: 1
Advances in engineered bacteria vaccines for enhancing anti-cancer immunity
Wu Liu, Wenjing Chen, Yujie Cai, et al.
Microbiome Research Reports (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Orthogonally Engineered Bacteria Capture Metabolically Labeled Tumor Antigens to Improve the Systemic Immune Response in Irradiated Tumors
Wen Xia, Zhuo Feng, Yuchen Wang, et al.
ACS Nano (2025) Vol. 19, Iss. 5, pp. 5376-5391
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top